Subscribe to Email Alerts
Menu
About Us
Company
Cancer Diagnostics Market
Board
Executive
Advisors
Partners
Distributors
Careers
Technology
Our Technologies
NETs Biomarker Capture Platform
SubB2M Pan-Cancer Probe
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Business Development
Products
Our Products
hTERT ICC Test
EXO-NET® (RUO)
FAQ
Pipeline
Diagnostics Pipeline
Investors
Snapshot
ASX Announcements
Reports
Presentations
Share Price Information
Analyst Coverage
Corporate Governance
Finance News Network Videos
Media
INOVIQ in the News
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Snapshot
ASX Announcements
Reports
Presentations
Share Price Information
Analyst Coverage
Corporate Governance
Finance News Network Videos
ASX Announcements
Filter by Year:
2022
2021
2020
2019
2018
2017
2016
16-May-2022
Change of Director's Interest - Philip Powell
10-May-2022
IIQ Investor Presentation
9-May-2022
Change of Director's Interest - Dr Geoffrey Cumming
4-May-2022
Change of Director's Interest - Philip Powell
3-May-2022
INOVIQ Investor Briefing Invitation
3-May-2022
Australian Patent Granted for SubB2M Technology
2-May-2022
INOVIQ Key Manufacturing Agreement to Advance SubB2M tests
29-Apr-2022
IIQ Appendix 4C & Quarterly Activities Report - March 2022
26-Apr-2022
INOVIQ CSO Co-Authors Scientific Statement on Exosomes
21-Apr-2022
Notification of cessation of securities - IIQ
1
2
3
Next
